Screener
Capricor Therapeutics CAPR Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
| Line item | March 31, 2026 / (unaudited) | December 31, 2025 | December 31, 2025 |
|---|---|---|---|
| OTHER ASSETS | |||
| Lease right-of-use assets, net | 13,158,500 | 13,537,820 | |
| Other assets | 1,533,591 | 1,159,480 | |
| TOTAL ASSETS | $326,283,517 | $ | $355,949,294 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||
| CURRENT LIABILITIES | |||
| Accounts payable | $3,927,941 | $ | $1,654,754 |
| Accrued expenses | 10,528,351 | 15,557,646 |
Item 1. Financial Statements.
FAQ
- What is Capricor Therapeutics's total assets?
- Capricor Therapeutics (CAPR) reported total assets of $326.28M in Q1 2026.
- How has Capricor Therapeutics's total assets changed year-over-year?
- Capricor Therapeutics's total assets increased by 112.2% year-over-year, from $153.77M to $326.28M.
- What is the long-term trend for Capricor Therapeutics's total assets?
- Over 5 years (2020 to 2025), Capricor Therapeutics's total assets has grown at a 59.4% compound annual growth rate (CAGR), from $34.62M to $355.95M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Capricor Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude